The US Food and Drug Administration (FDA) has granted Alleviant Medical an investigational device exemption (IDE), enabling ...

CereVasc announced today that it received FDA breakthrough device designation for its investigational eShunt system.

Now, researchers have designed a shunt that expands when activated by light. If developed successfully, this device could reduce the number of open-chest surgeries these children receive.

CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today ...